siRNA干扰PDGF对新生儿血管瘤干细胞的增殖和分化的影响

婴儿血管瘤是一种血管瘤,表现出独特的快速生长的特征,然后随着时间而消退。血管瘤来自CD133+干细胞,当植入免疫缺陷小鼠时,它们分化成内皮细胞。同样克隆扩增的干细胞也产生脂肪细胞,从而重现血管瘤的消退期。本研究主要阐明了使用血管瘤来源的干细胞(hemSC)增殖和分化的内在机制。本研究发现血小板衍生生长因子(PDGF)在增殖期升高并可能抑制脂肪细胞分化。hemSC表达高水平的PDGF-b并且在基础(未刺激)条件下显示PDGF受体的持续酪氨酸磷酸化。PDGF受体信号传导的抑制导致hemSCs中的脂肪生成增强。此外,hemSCs暴露于外源性PDGF-b降低了脂肪含量和脂肪细胞特异性转录因子的表达。总之,本研究将PDGF信号传导鉴定为血管瘤退化的内在负调节因子,并强调了破坏PDGF信号传导治疗血管瘤的治疗潜力。     

抑制数个激酶的新药上市改变了药物治疗状况

由于抗癌剂难以奏效，肾细胞癌首选的药物治疗方法还是使用免疫赋活剂。     

The RAF family：an expanding network of post—traslational controls and protein—protein interactions

Protein kinase RAF is strategically located in the “Ras-MAP-kinase signal transduction pathway“,a principle system which transmits signals from growth factor receptors to the nucleus,resulting in cell proliferation.Growth factor responses are mediated in part by activation of Ras,which in turn activates RAF to phosphorylate MEK,its downstream substrate.MEK activates MAPkinase to in fluence nuclear events.it is clear.however,that a network of signals other than those carred by Ras plays a role in RAF regulation.These orthogonal influences are mediated bu:serine/threonine kinases,tyrosine kinases,and protein-protein interactions.As a further complication to the RAF network,three isoforms of RAF have been established which have divergent N-terminal regulatory domains,Whereas these divergent regulatory domains implicate isoform-specific functions,no clear evidence or hypothesis for distinct functions for individual isoforms has been presented.Recently,“isoform-specific protein interactions“have been identified among numerous proteins interacting with RAF,These studies may serve to delineate independent functions for RAF isoforms.